News
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...
The U.S. has detected the NB.1.8.1 COVID-19 variant, dominant in China, through airport screenings and health departments ...
21h
Zacks Investment Research on MSNPharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & MoreNovo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...
A new COVID-19 variant, NB.1.8.1, linked to a surge in cases across China and parts of Asia, has now been detected in the ...
Cases linked to the NB.1.8.1 variant have been reported in arriving international travelers at airports in California, ...
After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder insulin product Exubera on 18 October. This was particularly bad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results